PRIME PubMed

+

Relationship of the reductive metabolism of indicine N-oxide to its antitumor activity.
Res Commun Chem Pathol Pharmacol 1979 Jun; 24(3):559-69.RC

Abstract

Several pyrrolizidine alkaloids have been demonstrated to have antitumor activity in experimental tumor systems. In general the free base form of the alkaloid exhibits greater biological activity than the corresponding N-oxide and the N-oxide must be metabolized to the base for the subsequent formation of alkylating intermediates. Indicine N-oxide is an exception in that it is a more active antitumor agent than its free base indicine. Studies of the antitumor activity and metabolism of indicine N-oxide, and the closely related compound, heliotrine N-oxide, given orally and intraperitoneally to mice bearing P-388 leukemia, suggest that conversion of indicine N-oxide to indicine is not essential for its antitumor activity.

Authors

Powis GNo affiliation info available
Ames MMNo affiliation info available
Kovach JSNo affiliation info available

MeSH

AnaerobiosisAnimalsAntineoplastic Agents, PhytogenicCyclic N-OxidesIn Vitro TechniquesLeukemia, ExperimentalMaleMiceMicrosomes, LiverOxidation-ReductionPyrrolizidine Alkaloids

Pub Type(s)

Journal Article
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

451340
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.